Antibacterial activities of peptides designed as hybrids of antimicrobial peptides

被引:0
作者
Keun Kim H. [1 ,2 ]
Gun Lee D. [1 ]
Park Y. [1 ]
Nam Kim H. [1 ]
Hwa Choi B. [1 ]
Choi C.-H. [2 ]
Hahm K.-S. [1 ]
机构
[1] Research Center for Proteineous Materials (RCPM), Chosun University
[2] Department of Pharmacology, Chosun University Medical School, Dong-ku, Kwangju 501-759
关键词
Antimicrobial peptide; Helicobacter pylori; Hemolytic activity;
D O I
10.1023/A:1014573005866
中图分类号
学科分类号
摘要
Hybrid peptides (HP-MA, HP-ME), each of 20 residues and incorporating 2-9 residues of Helicobacter pylori ribosomal protein L1 (HP) and 1-12 residues of magainin 2 and melittin, were designed. The antibiotic activities of these peptides were evaluated using bacterial, tumor and human erythrocyte cells. HP-MA had a stronger antibacterial activity against Gram-positive bacteria and Gram-negative bacteria than HP (2-20) and magainin 2, and HP-ME was similar to melittin. None of the hybrids had anti-tumor or hemolytic activity. These peptides were further investigated using an artificial liposomal vesicle and 1,6-diphenyl-1,3,5-hexatriene as a membrane probe, and confirmed to have similar antibacterial activities. The antibacterial effect of these hybrids is probably caused by their ability to damage the bacterial plasma membrane. Additional circular dichroism spectra suggested that the α-helical structure of these peptides plays an important role in their antibiotic effect but that α-helical property is less connected with the enhanced antibiotic activity.
引用
收藏
页码:347 / 353
页数:6
相关论文
共 14 条
[1]  
Andreu D., Ubach J., Boman A., Wahlin D., Wade D., Merrifield R.B., Boman H.G., Shortened cecropin A-melittin hybrids: Significant size reduction retains potent antibiotic activity, FEBS Lett., 296, pp. 190-194, (1992)
[2]  
Binenbaum Z., Parola A.H., Zaritzky A., Fishov I., Transcription- and translation-dependent changes in membrane dynamics in bacteria: Testing the transertion model for domain formation, Mol. Microbiol., 32, pp. 1173-1182, (1999)
[3]  
Boman H.G., Wade D., Boman A., Wahlin B., Merrifield R.B., Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids, FEBS Lett., 259, pp. 103-106, (1989)
[4]  
Chen H.-C., Brown J.H., Morell J.L., Huang C.M., Synthetic magainin analogues with improved anti-microbial activity, FEBS Lett., 236, pp. 462-466, (1988)
[5]  
Lee D.G., Shin S.Y., Kim D.-H., Seo M.Y., Kang J.H., Lee Y., Kim K.L., Hahm K.-S., Antifungal mechanism of cysteine-rich antimicrobial peptide, Ib-AMPI, from Impatiens balsamina against Candida albicans, Biotechnol. Lett., 21, pp. 1047-1050, (1999)
[6]  
Lee D.G., Shin S.Y., Maeng C.-Y., Hahm K.-S., Cecropin A-melittin hybrid peptide exerts its antifungal effects by damaging on the plasma membranes of Trichosporon beigelii, Biotechnol. Lett., 20, pp. 211-214, (1998)
[7]  
MacDonald R.C., MacDonald R.I., Menco B.P., Takeshita K., Subbarao N.K., Hu L.-R., Small-volume extrusion apparatus for preparation of large, unilamellar vesicle, Biochim. Biophys. Acta, 1061, pp. 297-303, (1991)
[8]  
Merrifield R.B., Solid phase synthesis, Science, 232, pp. 341-347, (1986)
[9]  
Ohsaki Y., Gazdar A.F., Chen H.C., Johnson B.E., Antitumor activity of magainin analogues against human lung cancer cell lines, Cancer Res., 52, pp. 3534-3538, (1992)
[10]  
Putsep K., Branden C.I., Boman H.G., Normark S., Antibacterial peptide from H. pylori, Nature, 398, pp. 671-672, (1999)